Financial Daily from THE HINDU group of publications
Tuesday, Nov 22, 2005
News
Features
Stocks
Shipping
Archives
Google

Group Sites

 Corporate - Announcements


Aurobindo gets USFDA nod for cephalexin

Our Bureau

HYDERABAD: Aurobindo Pharma Ltd has announced that the US Food and Drug Administration (FDA) has approved its Cephalexin capsules 250 mg and 500 mg.

In a press release here on Monday, the company said this is the first product approval from its dedicated Cephalosporin facility at unit-VI in Medak district of Andhra Pradesh.

At present, products from unit-III alone are contributing to the company's sales in the US.

The company expects to capitalise on the US FDA approvals for the products from units XII and VI.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

More Stories on : Announcements

Stories in this Section
GlaxoSmithKline to cast clinical research net in India beyond cancer

Apollo Hospitals in expansion mode
Aurobindo gets USFDA nod for cephalexin
Hunt for independent directors: Prime Database lists 8,500 professionals
Infosys in MAKE Hall of Fame
GTL, Global Infrastructure boards okay restructure proposals
JSW Steel declares merger ratio for 3 companies
IOC commissions hydrogen unit at Panipat refinery
IOC revives Paradip project
NLC, TNEB float co for 1,000-MW project in TN
`Cement prices have risen due to demand supply concern'
IDPL to submit revival package to BIFR soon
Sky Palace to wet lease aircraft for operations
Honda may again hike production capacity after Civic launch
`MyTVS' brand looks for sustained growth

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line